Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MedinCell

MedinCell?uq=AFYHfsyn
2002 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
MEDCL STOCK SYMBOL
$8.29 SHARE PRICE (As of Friday Closing)
Description

Developer of long-acting injections in France. The company develops next-generation therapeutic solutions and has a wide network of partners, providing for-profit and non-profit projects, pharmas, physicians, biotech firms, academics and foundations with affordable products that are available regardless of the local economic conditions.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Stock Exchange
PAR
Primary Office
  • 3 rue des Frères Lumière
  • 34830 Jacou
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MedinCell’s full profile, request a free trial.

MedinCell Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$8.28 - $8.47 $165M $8.30 27.3K 19.9M

MedinCell Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
FY 2016
31-Mar-2016
Revenue 7,519 7,519 9,359 9,078
EBITDA (7,901) (7,901) (3,346) 841
Net Income (11,178) (11,178) (3,906) 686
Total Assets 31,258 31,258 24,861 12,661
Total Debt 38,216 38,216 22,125 4,898
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MedinCell Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MedinCell‘s full profile, request access.

Request full access to PitchBook

MedinCell Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MedinCell‘s full profile, request access.

Request full access to PitchBook

MedinCell Executive Team (4)

Name Title Board
Seat
Contact
Info
Anh N'Guyen Ph.D Co-Founder, President & Chief Executive Officer
Nicolas Heuze Chief Financial Officer & Executive, Corporate Development
David Heuze Chief Communication Officer
Christophe Douat Co-Founder & Chairman of the Management Board

MedinCell Board Members (1)

Name Representing Role Since Contact
Info
0000000000 00000 MedinCell Co-Founder & Chairman of the Management Board 000 0000